Listen: Can California lower the price of insulin?

By Kaiser Health News
| July 27, 2022

California lawmakers set aside $100 million in the recently adopted 2022-23 state budget to help launch the CalRx drug label, and the state could start producing generic insulin within the next few years.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...